載入...
NGcGM3 Ganglioside: A Privileged Target for Cancer Vaccines
Active specific immunotherapy is a promising field in cancer research. N-glycolyl (NGc) gangliosides, and particularly NGcGM3, have received attention as a privileged target for cancer therapy. Many clinical trials have been performed with the anti-NGc-containing gangliosides anti-idiotype monoclona...
Na minha lista:
Main Authors: | , , , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
Hindawi Publishing Corporation
2010
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2965427/ https://ncbi.nlm.nih.gov/pubmed/21048926 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2010/814397 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|